A Two Part, Multi-Centre, Randomized, Placebo-Controlled, Double-Blind Study of TRK-170 for the Treatment of Crohn's Disease.
Phase of Trial: Phase II
Latest Information Update: 04 Nov 2014
At a glance
- Drugs TRK-170 (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Sponsors Toray
- 10 Jun 2017 Biomarkers information updated
- 11 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.